Search Results 91-100 of 28547 for crohns disease

1. Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease - Mayo Clinic

   ... Crohn's disease (CD). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

2. Pilot Study on FDG PET/MRE for Stricture Assessment in Crohn’s Disease - Mayo Clinic

   ... Crohn's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

3. Treatment response and management of biologics in patients with ECD - Mayo Clinic

   Esophageal Crohn's disease (ECD) is a rare, aggressive form of inflammatory bowel disease (IBD). Patients with ECD often present with inflammation, ...

4. Mayo Clinic Radio: IBD / food allergies / Convergence Science Program

   Inflammatory bowel disease (IBD) is an umbrella term used to describe disorders that involve chronic inflammation of the digestive tract. There are two ...

5. Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease - Mayo Clinic

   ... Crohn's disease (CD). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

6. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

   The SECURE Registry's target enrollment is 4000 patients and it's objective is to monitor patients for approximately 10 years. Participation eligibility.

7. Microscopic colitis - Symptoms and causes - Mayo Clinic

   Symptoms, testing and treatment are the same for both subtypes. Products & Services. A Book: Mayo Clinic on Crohn's Disease and Ulcerative Colitis · A Book ...

8. A Study of the Effectiveness and Safety of Mongersen (GED-0301) for the Treatment of Patients with Active Crohn's Disease - Mayo Clinic

   The purpose of this study is to test the effectiveness and safety of an experimental medication GED-0301 (mongersen) in patients who have active Crohn's disease ...

9. An Extension Study Monitoring the Safety of Patients with Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 - Mayo Clinic

   ... Crohn's disease who were previously enrolled in the etrolizumab Phase III Study GA29144. ... Participant eligibility includes age, gender, type and stage of ...

10. A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease - Mayo Clinic

    Clinical Trials · A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease · More about research at Mayo Clinic · Mayo Clinic Footer.